Symtuza Europeiska unionen - isländska - EMA (European Medicines Agency)

symtuza

janssen-cilag international nv - darunavir, cobicistat, meðferð með eviplera nýrnastarfsemi alafenamide - hiv sýkingar - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - symtuza er ætlað til meðferðar við hiv-1 sýkingu af völdum hiv-1 sýkingar hjá fullorðnum og unglingum (12 ára og eldri með líkamsþyngd að minnsta kosti 40 kg). genotypic testing should guide the use of symtuza.

Nerlynx Europeiska unionen - isländska - EMA (European Medicines Agency)

nerlynx

pierre fabre medicament - neratinib - brjóstakrabbamein - Æxlishemjandi lyf - nerlynx er ætlað til lengri viðbótar meðferð fullorðinn sjúklinga með snemma hormón viðtaka jákvæð her2-overexpressed/magnað brjóstakrabbamein og hver eru minna en ár frá að ljúka áður en viðbótar trastuzumab byggt meðferð.

Lumeblue (previously known as Methylthioninium chloride Cosmo) Europeiska unionen - isländska - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metýlþíóníumklóríð - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Hepcludex Europeiska unionen - isländska - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - veirueyðandi lyf til almennrar notkunar - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Copiktra Europeiska unionen - isländska - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Lumykras Europeiska unionen - isländska - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Fluconazol Krka Hart hylki 150 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

fluconazol krka hart hylki 150 mg

krka sverige ab - fluconazolum inn - hart hylki - 150 mg

Diflucan Mixtúruduft, lausn 10 mg/ml Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

diflucan mixtúruduft, lausn 10 mg/ml

pfizer aps - fluconazolum inn - mixtúruduft, lausn - 10 mg/ml

Candizol Hart hylki 150 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

candizol hart hylki 150 mg

actavis group ptc ehf. - fluconazolum inn - hart hylki - 150 mg

Candizol Hart hylki 200 mg Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

candizol hart hylki 200 mg

actavis group ptc ehf. - fluconazolum inn - hart hylki - 200 mg